Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 8/2010

01-08-2010 | Breast Oncology

Intraoperative Imprint Cytology Examination of Sentinel Lymph Nodes After Neoadjuvant Chemotherapy in Breast Cancer Patients

Authors: P. Gimbergues, MD, M. M. Dauplat, MD, X. Durando, MD, PhD, C. Abrial, PhD, G. Le Bouedec, MD, M. A. Mouret-Reynier, MD, F. Cachin, MD, F. Kwiatkowski, MSc, Andrei Tchirkov, MD, PhD, J. Dauplat, MD, PhD, F. Penault-Llorca, MD, PhD

Published in: Annals of Surgical Oncology | Issue 8/2010

Login to get access

Abstract

Background

Intraoperative imprint cytology (IC) is one of several accurate, proven methods to detect tumor cells in sentinel lymph nodes (SLN) from patients with operable breast cancer. In patients treated with neoadjuvant chemotherapy (NAC), studies have demonstrated the feasibility and accuracy of SLN biopsy procedure. We evaluated the validity of IC for SLN testing in patients after NAC.

Material and Methods

Patients with infiltrating breast carcinoma receiving NAC (n = 132) were studied prospectively. At surgery, SLN biopsy followed by axillary lymph node dissection was performed. SLN were evaluated using IC in 80 of 132 patients (60%). The results of IC in the adjuvant setting (100 patients) were used for comparison.

Results

SLN metastases were correctly identified using IC in 58 of 80 (72%) patients. False negative results were observed in 21 patients. The sensitivity of IC testing was 38.2% and specificity 97.8%. The positive and negative predictive values (PPV and NPV) were 92.9% and 68.2%, respectively. In univariate analysis and multivariate logistic regression analysis, patients with micrometastases or isolated tumor cells in SLN have 2.3 times higher risk of a false negative IC result than patients with macrometastases in SLN (P = .00021; relative risk [RR] = 2.3; 95% confidence interval, 1.37–3.85). The non-NAC group, which contained fewer micrometastatic cases, showed better sensitivity (47.4%) and NPV (88.9%).

Conclusion

NAC does not seem to influence the accuracy and sensitivity of IC. Variations in sensitivity are related to the proportion of cases with micrometastases and ITC, as it was also shown in chemonaive patients.
Literature
1.
Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2:335–59.CrossRefPubMed
2.
Schwartz GF, Giuliano AE, Veronesi U, and the Consensus Conference Committee. Proceedings of the consensus conference on the role of sentinel node biopsy in carcinoma of the breast April 19–22, 2001, Philadelphia, Pennsylvania. Hum Pathol. 2002;6:579–89.
3.
Motomura K, Nagumo S, Komoike Y, Koyama H; Inaji H. Intraoperative imprint cytology for the diagnosis of sentinel metastases in breast cancer. Breast Cancer. 2007;14:350–4.CrossRefPubMed
4.
Fisher B, Brown A, Mamounas E, Wieand S, Robidoux A, Margolese RG, et al. Effect of preoperative chemotherapy on local regional disease in women with operable breast cancer: Finding from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol. 1997;15:2483–93.PubMed
5.
Bonadonna G, Veronesi U, Brambilla C, Ferrari L, Luini A, Greco M, et al. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst. 1990;82:1539–45.CrossRefPubMed
6.
Cohen LF, Breslin TM, Kuerer HM, Ross MI, Hunt KK, Sahin AA. Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy. Am J Surg Pathol. 2000;24:1266–72.CrossRefPubMed
7.
Sharkey FE, Addington SL, Fowler LJ, Page CP, Cruz AB. Effects of preoperative chemotherapy on the morphology of resectable breast carcinoma. Mod Pathol. 1996;9:893–900.PubMed
8.
Honkoop AH, Pinedo HM, De Jong JS, Verheul HM, Linn SC, Hoekman K, et al. Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer. Am J Clin Pathol. 1997;107:211–8.PubMed
9.
Kuerer HM, Sahin AA, Hunt KK, Newman LA, Breslin TM, Ames FC, et al. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patient treated with neoadjuvant chemotherapy for breast cancer. J Clin Oncol. 2000;18:3480–6.PubMed
10.
Haid A, Tausch C, Lang A, Lutz J, Fritzsche H, Peschina W, et al. Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma? Cancer. 2001;92:1080–4.CrossRefPubMed
11.
Tafra L, Verbanac KM, Lannin DR. Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer. Am J Surg. 2001;182:312–5.CrossRefPubMed
12.
Brady EW. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer. Breast J. 2002;8:97–100.CrossRefPubMed
13.
Miller AR, Thomason VE, Yeh IT, Alrahwan A, Sharkey FE, Stauffer J, et al. Analysis of sentinel lymph node mapping with immediate pathologic review in patients receiving preoperative chemotherapy for breast carcinoma Ann Surg Oncol. 2002;9:243–7.CrossRefPubMed
14.
Julian TB, Dusi D, Wolmark N. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg. 2002;184:315–7.CrossRefPubMed
15.
Balch GC, Mithani SK, Richards KR, Beauchamp RD, Kelley MC. Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer. Ann Surg Oncol. 2003;10:616–21.CrossRefPubMed
16.
Reitsamer R, Peintinger F, Rettenbacher L, Prokop E. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. Surg Oncol. 2003;84:63–7.CrossRef
17.
Lang JE, Essermann LJ, Ewing CA, Rugo HS, Lane KT, Leong SP, et al. Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation. J Am Coll Surg. 2004;199:855–62.CrossRef
18.
Classe JM, Bordes V, Campion L, Mignotte H, Dravet F, Leveque J, et al. Sentinel lymph nodes biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion sentinelle et chimiothérapie neoadjuvante, a French prospective multicentric study. J Clin Oncol. 2009;27:726–32.CrossRefPubMed
19.
Gimbergues P, Abrial C, Durando X, Le Bouedec G, Cachin F, Penault-Llorca F, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation. Ann Surg Oncol. 2008;15:1316–21.CrossRefPubMed
20.
Motomura K, Inaji H, Komoike Y, Kasugai T, Nagumo S, Noguchi S, et al. Intraoperative sentinel lymph node examination by imprint cytology and frozen section during breast surgery. Br J Surg. 2000;87:597–601.CrossRefPubMed
21.
Henry-Tillman RS, Korourian S, Rubio IT, Johnson AT, Mancino AT, Massol N, et al. Intraoperative touch preparation for sentinel lymph node biopsy: a 4-year experience. Ann Surg Oncol. 2002;9:333–9.CrossRefPubMed
22.
Barranger E, Antoine M, Grahek D, Callard P, Uzan S. Intraoperative imprint cytology fo sentinel lymph nodes in breast cancer. J Surg Oncol. 2004;86:128–33.CrossRefPubMed
23.
Cox C, Centeno B, Dickson D, Clark J, Nicosia S, Dupont E, et al. Accuracy of intraoperative imprint cytology for sentinel lymph node evaluation in the treatment of breast carcinoma. Cancer. 2005;105:13–20.CrossRefPubMed
24.
Chicken DW, Kocjan G, Falzon M, Lee AC, Douek M, Sainsbury R, et al. Intraoperative touch imprint cytology for the diagnosis of sentinel lymph node metastases in breast cancer. Br J Surg. 2006;93:572–6.CrossRefPubMed
25.
Creager AJ, Geisinger KR, Shiver SA, Perrier ND, Shen P, Ann Shaw J, et al. Intraoperative evaluation of sentinel lymph nodes for metastatic breast carcinoma by imprint cytology. Mod Pathol. 2002;15:1140–7.CrossRefPubMed
26.
Zgajnar J, Frkovic-Grazio S, Besic N, Hocevar M, Vidergar-Kralj B, Gerljevic A, et al. Low sensitivity of touch imprint cytology of the sentinel lymph node in breast cancer patients—results of a large series. J Surg Oncol. 2004;85:82–6.CrossRefPubMed
27.
Kane JM III, Edge SB, Winston JS, Watroba N, Hurd TC. Intraoperative pathologic evaluation of a breast cancer sentinel lymph node biopsy as a determinant for synchronous axillary lymph node dissection. Ann Surg Oncol. 2001;8:361–7.CrossRefPubMed
28.
Contractor K, Gohel M, Al-Salami E, Kaur K, Aqel N, Nigar E, et al. Intra-operative imprint cytology for assessing the sentinel node in breast cancer-Results of its routine use over 8 years. Eur J Surg Oncol. 2009;35:16–20.PubMed
29.
Tew K, Irwig L, Matthews A, Crowe P, Macaskill P. Meta-analysis of sentinel node imprint cytology in breast cancer. Br J Surg. 2005;92:1068–80.CrossRefPubMed
30.
Jain P, Kumar R, Anand M, Asthana S, Deo SV, Gupta R, et al. Touch imprint cytology of axillary lymph nodes after neoadjuvant chemotherapy in patients with breast carcinoma. Cancer. 2003;99:346–51.CrossRefPubMed
31.
Komenaka IK, Torabi R, Nair G, Jayaram L, Hsu CH, Bouton ME, et al. Intraoperative touch imprint and frozen section analysis of sentinel lymph nodes after neoadjuvant chemotherapy for breast cancer. Ann Surg. 2010;251:319–22.CrossRefPubMed
32.
Pugliese MS, Khor JR, Allison KH, Wang NP, Tickman RJ, Beatty JD. Accuracy of intraoperative imprint cytology of sentinel lymph nodes in breast cancer. Am J Surg. 2006;192:516–9.CrossRefPubMed
33.
Rubio IT, Aznar F, Lirola J, Peg V, Xercavins J. Intraoperative assessment of sentinel lymph nodes after neoadjuvant chemotherapy in patients with breast cancer. Ann Surg Oncol. 2010; 17:235–9.CrossRefPubMed
34.
Shimazu K, Tamaki Y, Taguchi T, Tsukamoto F, Kasugai T, Noguchi S. Intraoperative frozen section analysis of sentinel lymph node in breast cancer patients treated with neoadjuvant chemotherapy. Ann Surg Oncol. 2008;15:1717–22.CrossRefPubMed
Metadata
Title
Intraoperative Imprint Cytology Examination of Sentinel Lymph Nodes After Neoadjuvant Chemotherapy in Breast Cancer Patients
Authors
P. Gimbergues, MD
M. M. Dauplat, MD
X. Durando, MD, PhD
C. Abrial, PhD
G. Le Bouedec, MD
M. A. Mouret-Reynier, MD
F. Cachin, MD
F. Kwiatkowski, MSc
Andrei Tchirkov, MD, PhD
J. Dauplat, MD, PhD
F. Penault-Llorca, MD, PhD
Publication date
01-08-2010
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 8/2010
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-0952-0

Other articles of this Issue 8/2010

Annals of Surgical Oncology 8/2010 Go to the issue

Bone and Soft Tissue Sarcomas

Soft Tissue Sarcoma of Extremities: The Prognostic Significance of Adequate Surgical Margins in Primary Operation and Reoperation After Recurrence

Hepatobiliary Tumors

Predictive Factors for Hypertrophy of the Future Remnant Liver After Selective Portal Vein Embolization

Colorectal Cancer

Stromal CXCR4 and CXCL12 Expression is Associated with Distant Recurrence and Poor Prognosis in Rectal Cancer After Chemoradiotherapy

Melanomas

Creating and Providing Predictions of Melanoma Outcome

Hepatobiliary Tumors

Sequenced Chemotherapy and Surgery for Potentially Resectable Colorectal Liver Metastases: A Debate Over Goals of Research and an Approach While the Jury Remains Out

Translational Research and Biomarkers

Positive Expression of L1-CAM is Associated with Perineural Invasion and Poor Outcome in Pancreatic Ductal Adenocarcinoma